Skip to main content
Fig. 1 | BMC Complementary Medicine and Therapies

Fig. 1

From: In vitro anti-HIV, cytotoxicity and nutritional analysis of Trianthema portulacastrum L. (Aizoaceae)

Fig. 1

a Inhibitory effect of T. portulacastrum extract (T01) against HIV-1 isolate. b: Inhibitory effect of T. portulacastrum extract (T02) against HIV-1 isolate. a & b: Percentage inhibition curves of the T. portulacastrum extracts (T01 and T02) with Luciferase-based antiviral assay using TZM-bl cell lines. The TZM-bl cells were infected with HIV-1 (NL4.3) and treated with the serial dilution of T. portulacastrum crude extracts with AZT as positive control. The infected and treated TZM-bl cells were incubated for 48hrs at 37°C and 5% CO2. IC50 for T01=1.757 mg/mL; IC50 for T02=1.205mg/mL

Back to article page